✦ LIBER ✦

Surgical management of transitional cell carcinoma of the lacrimal sac: Is it time for a new treatment algorithm?

✍ Scribed by Shofiq Islam; Alexandria Thomas; Robert L. Eisenberg; Gary R. Hoffman

Book ID: 119203242
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 610 KB
Volume: 65
Category: Article
ISSN: 1878-0539
DOI: 10.1016/j.bjps.2011.09.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective comparison of the NMP22 Bl

A prospective comparison of the NMP22 BladderChek® assay and voided urine cytology in the detection of bladder transitional cell carcinoma: Is it time up for urine cytology?

✍ Shalom J. Srirangam; Rajendar Marri; Ann Crump; Thiru Gunendran; Donald Neilson 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 106 KB

Use of a New Tumor Marker, Urinary NMP22

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

✍ SOLOWAY, M; BRIGGMAN, J; CARPINITO, G; CHODAK, G; CHURCH, P; LAMM, D; LANGE, P; 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 528 KB

Management of Well-Differentiated Thyrog

Management of Well-Differentiated Thyroglossal Remnant Thyroid Carcinoma: Time To Close the Debate? Report of Five New Cases and Proposal of a Definitive Algorithm for Treatment

✍ César P. Ramírez Plaza; Marta E. Domínguez López; Carmen Eloy-García Carrasco; L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 405 KB

The emerging role of targeted therapy in

The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach?

✍ Alessandro Sciarra; Susanna Cattarino; Stefano Salciccia; Andrea Alfarone; Aless 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 618 KB

The aryl hydrocarbon receptor (AHR) is a

The aryl hydrocarbon receptor (AHR) is a new target for prevention and treatment of cutaneous squamous cell carcinomas

✍ Haarmann-Stemmann, Thomas; Frauenstein, Katrin; Tigges, Julia; Fischer, Kerstin; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Paying for the Orphan Drug System: break

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

✍ Wills Hughes-Wilson, Ana Palma, Ad Schuurman… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 213 KB